StratumSkin science, cited

Skin of colour

Where melanin-rich skin needs more than a footnote

Most dermatology trials, textbook photos and marketing claims default to lighter skin. That shows up in real ways for skin of colour — Black, South Asian, East Asian, Hispanic and Middle Eastern skin among others: conditions that look and present differently, a much higher post-inflammatory pigmentation and keloid risk, treatments that need retuning rather than just reusing, and whole topics (razor bumps, traction alopecia) that barely exist in mainstream skincare content at all. This page pulls together everything on the site that speaks to that directly, still graded on the same A–D scale as everywhere else — nothing here is graded more generously for appearing on this page.

Most dermatology trials and textbook photos default to lighter skin

Fitzpatrick I–III skin is overrepresented in both the clinical trials behind most ingredient grades and the reference photos clinicians train on. That doesn't make the underlying findings wrong, but it does mean some conditions look different than the reference picture, present later, or get treated with an ingredient tested mainly on skin unlike the reader's. Where we know a study specifically included darker skin, the reference note says so.

Pigmentation & melasma hub

Post-inflammatory hyperpigmentation is often the bigger complaint than what caused it

Acne, eczema and psoriasis all can leave marks that outlast the original flare by months, and in medium-to-deep skin tones that mark is often what actually brings someone to a dermatologist or this site. It tilts good treatment choice toward options less likely to irritate in the first place, since irritation itself can trigger more of it.

Acne hub

Visible light matters here, not just UV

Melasma and post-inflammatory marks respond to visible light on top of UV, and a plain SPF number says nothing about that. An independent trial found iron-oxide-tinted sunscreen measurably boosted hydroquinone's own treatment effect; a separate, industry-funded trial found less relapse afterward with the same kind of sunscreen versus a clear or white one at the same SPF.

Pigmentation & melasma hub

Keloid risk is one of dermatology's best-documented skin-of-colour differences

The gap in keloid incidence by skin tone is large and consistently replicated, which makes it worth mentioning to a dermatologist before an elective piercing, tattoo or procedure if you or a close relative scars this way — a five-minute conversation ahead of time beats months of treating a keloid afterward.

Keloid & scar-prone skin hub

Razor bumps are a mainstream skincare blind spot

Pseudofolliculitis barbae is overwhelmingly a problem of tightly curled hair curling back into the skin after a close shave, which makes it far more common in Black men than the generic shaving-tips content most razor marketing is written for ever accounts for. The definitive fixes (growing out, laser, a guarded trimmer) are more effective than almost anything applied on top of the bumps themselves.

Razor bumps (pseudofolliculitis barbae) hub

A widely repeated hair-loss cause turned out to be only part of the story

Central centrifugal cicatricial alopecia was blamed on relaxers and tight hairstyles for years. A 2019 genetics study found an identifiable gene variant in about a quarter of patients tested, including some who never used those practices, which complicates the tidy single-cause version still repeated across a lot of hair-care content — without genetics alone explaining most cases either.

Traction alopecia & CCCA hub

Condition hubs

Full hubs where skin-of-colour presentation, risk or treatment nuance is significant enough to call out on the page itself.

Acne

Blocked pores, inflammation and, for a lot of people, hormones. It has more evidence-backed treatments than almost any other skin condition, and more hype layered on top of them than almost any other, too.

10 ingredients · 4 articlesSkin of colour

Pigmentation & melasma

Dark spots, patches and the marks acne or irritation leave behind. One of the most common reasons people in India end up on this site, and one of the categories where marketing most outpaces the trials.

10 ingredients · 2 articlesSkin of colour

Keloid & scar-prone skin

Scars that keep growing past the original wound, thicken, or itch for months rather than fading. More common in darker skin tones, and a genuine source of anxiety around ordinary things like ear piercing, vaccination sites or acne itself.

2 ingredients · 0 articlesSkin of colour

Eczema

Dry, itchy, inflamed patches that flare and settle in cycles, often starting in childhood. The evidence base for treating it is unusually deep and Cochrane-reviewed, which makes this one of the more confident, well-sourced hubs on this site rather than one built on thinner ground.

7 ingredients · 1 articlesSkin of colour

Psoriasis

Thick, well-demarcated plaques with silvery scale, driven by an overactive immune response rather than anything applied to the skin from outside. A chronic, cyclical condition with a genuinely deep prescription-treatment evidence base, even though the shelf of over-the-counter options for it is thinner than the marketing around some of them suggests.

4 ingredients · 0 articlesSkin of colour

Razor bumps (pseudofolliculitis barbae)

Small, inflamed bumps where shaved hair curls back into the skin instead of growing straight out. Overwhelmingly a problem for tightly curled facial and body hair, which makes it far more common in Black men than the generic 'shaving tips' advice most razor marketing is written for ever acknowledges.

3 ingredients · 0 articlesSkin of colour

Traction alopecia & CCCA

Two different kinds of hair loss that get treated as one: traction alopecia is mechanical damage from pulling on hair, and reverses if caught early; central centrifugal cicatricial alopecia (CCCA) is a scarring alopecia that starts at the crown, disproportionately affects Black women, and has a real genetic component that a simple 'it's the hairstyle' story misses.

0 ingredients · 1 articlesSkin of colour

Post-inflammatory hyperpigmentation (PIH)

The dark mark left behind after a pimple, cut, rash or peel heals — not the same condition as melasma, even though the two get treated as interchangeable constantly. Unlike melasma, it usually fades on its own once its trigger is gone, which changes how aggressively it's worth treating.

7 ingredients · 2 articlesSkin of colour

Vitiligo

Patches of skin that lose their pigment entirely, from an autoimmune process that attacks melanocytes rather than from anything applied to the skin from outside. For most of dermatology's history, camouflage and steroid creams were most of what was on offer. That has genuinely changed.

4 ingredients · 0 articlesSkin of colour

Ingredients worth knowing about

Pulled from the hubs above — nothing here is a separate grade from the Ingredient Index.

A
Azelaic acidFrom grains, oddly
Quietly brilliant and weirdly under-used. Handles rosacea, acne and the brown marks acne leaves behind, all with decent evidence. Also one of the few actives considered safe in pregnancy.
RosaceaAcnePigmentation
15–20%
A
Benzoyl peroxideBPO
Kills acne bacteria without them becoming resistant, which is why doctors pair it with antibiotics. 2.5% works as well as 10% and irritates far less, so the strong version is mostly a way to sell you irritation. It bleaches towels and pillowcases. All of them.
AcneIngrown hairs (pseudofolliculitis barbae)
2.5–5%
A
HydroquinoneSkin-lightening agent
Still the most effective topical for melasma when tested head-to-head. Restricted or prescription-only in many countries, and meant to be used in defined courses rather than forever. Not a daily-serum ingredient.
Pigmentation
2–4%, in courses
B
CysteamineTopical, from an amino acid
One of the few non-prescription pigment treatments with proper controlled trials, including comparisons against hydroquinone. The catch is the smell, which is memorably unpleasant and the main reason people stop.
Pigmentation
5%
B
EflornithinePrescription topical, brand name Vaniqa
The best-evidenced topical option specifically for unwanted facial hair, backed by the kind of large, double-blind, vehicle-controlled trials that earned it FDA approval. The honest caveat that gets lost in the marketing: it slows hair regrowth, it does not remove hair or treat what's causing it, and the effect fades within weeks of stopping. It's a maintenance cream, not a cure, and it's usually paired with a hair-removal method rather than replacing one. That combination role is also its best-evidenced use in razor bumps: paired with laser hair removal, it measurably outperforms laser alone.
PCOS-driven acne & hirsutismIngrown hairs (pseudofolliculitis barbae)
13.9% cream, twice daily
B
Iron oxidesTinted mineral sunscreen pigment
A plain SPF number only describes UV protection. Iron oxides are what give a sunscreen its tint, and that tint is also what blocks visible light, including the blue-violet end of the spectrum that ordinary UV filters let straight through. That distinction matters specifically for melasma and post-inflammatory dark marks, which visible light can trigger and worsen on its own, sunburn or not. This isn't a stand-alone treatment: it only adds anything on top of a real UV filter, and it does nothing for the vascular or structural causes of dark under-eye circles or any pigmentation unrelated to melanin.
Pigmentation
Present in most 'tinted' mineral or hybrid sunscreens; concentration rarely disclosed
B
NiacinamideVitamin B3
Excellent for a damaged barrier, decent and slow for dark spots, largely irrelevant for wrinkles. Almost nobody reacts to it. There is no published evidence that 10% beats 5%, whatever the packaging suggests.
BarrierPigmentationOil
2–5%
B
RuxolitinibTopical JAK inhibitor (Opzelura)
The first topical drug with genuine randomised-trial evidence for actually restoring pigment in vitiligo, not just slowing its spread. Roughly twice as many people regained visible facial colour on ruxolitinib as on a plain vehicle cream over six months, with results still building at a year. It's a JAK inhibitor, which brings an FDA boxed warning inherited from oral drugs in the same class — a conversation to have with a dermatologist, not a self-prescribing decision.
Vitiligo
1.5% cream, twice daily
B
Salicylic acidBHA
Oil-soluble, so it gets down inside the pore where the blockage actually is. Best for blackheads and congestion rather than angry red spots.
AcneTextureOilPsoriasisIngrown hairs (pseudofolliculitis barbae)
0.5–2%
B
ThiamidolIsobutylamido thiazolyl resorcinol
A strong tyrosinase blocker. Tyrosinase is the enzyme skin uses to make pigment, so blocking it slows new pigment production. There's human trial data behind it for melasma and sun spots. Nearly all of that research comes from Beiersdorf, who patented it and sell it, so treat the size of the effect with a degree of caution.
Pigmentation
0.1–1%
B
Tranexamic acidTopical TXA
Interrupts one of the pathways that drives melasma specifically. Results are consistent and smaller than the oral version, which has clotting risks and needs a doctor.
Pigmentation
3–5%
C
Alpha arbutinReleases hydroquinone slowly
Chemically a gentler cousin of hydroquinone, and marketed as the safe version of it. Human studies exist but are small and often run by suppliers. Plausible, mild, and nowhere near as well tested as the thing it imitates.
Pigmentation
1–2%
C
Kojic acidFrom fermented rice
Blocks pigment production in the lab convincingly and in people inconsistently. Most human trials pair it with something else, so untangling its own contribution is difficult. Also one of the more common causes of contact allergy on this list.
Pigmentation
1–2%
C
Silicone gel sheetsScar treatment, worn as sheets or applied as gel
The most-studied topical scar treatment on the market, and often described as first-line. But the Cochrane reviews behind that reputation are more hedged than the reputation suggests. Real trials exist, more of them than for anything else we found for scarring, and Cochrane's own language is 'weak evidence' and 'poor quality,' not a ringing endorsement. It is, in other words, the most rigorously studied shrug in dermatology. Worth trying, priced and framed as a reasonable first step rather than a proven fix.
Keloid & scar-prone skin
Worn 12–24 hours/day over a scar for 2–3 months
D
Onion extractAllium cepa extract gel, e.g. Mederma-type products
One of the most heavily marketed scar treatments, and one of the more disappointing ones once you look past the marketing. The cleanest trial we found (small, well-designed, split-scar, so each person acts as their own control) found no difference from plain petrolatum, which costs a fraction of the price and won't make your bathroom smell like a kitchen. A larger positive trial exists, but it was funded by the company selling the product and compared each scar against its own untreated half rather than a separate control gel. A meta-analysis on this exact question is, by its own title, unconvinced.
Keloid & scar-prone skin
Gel, applied several times daily

Related articles

B
IngredientsAzelaic Acid: Does It Actually Work?Azelaic acid treats acne, helps some forms of pigmentation, and has a surprisingly decent evidence base. But how much of the skincare hype does the research actually support?
5 min
6 sources
B
ConditionsTraction alopecia and CCCA: what a hairstyle can and can't causeOne of these is straightforwardly caused by pulling on hair, and reverses if you catch it early. The other was blamed on hairstyling for decades before a 2019 genetics paper complicated that story. They get treated as the same condition far more often than the evidence supports.
6 min
6 sources
B
ConditionsMelasma vs. post-inflammatory hyperpigmentationTwo different conditions, two different playbooks, one very confused skincare aisle.
9 min
6 sources
B
TreatmentsMicroneedling for acne scars: depth is the whole conversationThe trials that show real improvement used depths and session counts that home rollers cannot reach. That's not a detail: it's the mechanism.
9 min
3 sources
C
Holistic healthSkin supplements: the few that hold up, and the many that don'tOne has genuinely strong evidence. One we have just downgraded. One is worth avoiding before a blood test. The rest are expensive urine.
11 min
6 sources
C
Holistic healthThe gut–skin connection: what's proven, what's plausible, what's inventedDiet does affect skin. Just not in the way most of the internet says, and not for most of the conditions it gets blamed for.
10 min
3 sources
B
IngredientsNiacinamide: what it actually does, one claim at a timeIt's in everything, it costs very little, and the bottle promises considerably more than the studies deliver.
8 min
6 sources
B
ProductsBarrier creams: the ratio matters more than the ingredient listCeramides get all the marketing. The research says it's the proportions that do the work, and the wrong proportions can slow healing down.
7 min
4 sources

Products checked against these ingredients

From the Products section — formulas that contain at least one ingredient listed above, checked the same way as every other product here: formula against claim, not the other way round.

The Sunday study

One paper a week, explained properly

We pick a single new study, tell you what it measured, how many people it measured it in, and whether it should change anything you're doing — plus the two articles we published that week. No panic, and no hype.

We don't recommend products yet. When we do, they'll be things you can actually buy in India, any affiliate link will be labelled as one, and a commission will never buy a recommendation.

One email each Sunday. Unsubscribe in one click.